Anavex Life Sciences Corp (AVXL)

[Investor2014]

I believe I compared the dose range results between the A3-71 and A2-73 P1 human trials.

But of course Anavex will ignore the 140mg broader dose range findings of A3-71 determined in a human P1 trial and eventually dose the next patients with up to 50,000 lower doses just to comply with an old preclinical paper based on murine results and two social media scientists.